A Study to Assess Immune Response Following Zoster Vaccination to Subjects With Rheumatoid Arthritis Receiving Tofacitinib or Placebo With Background Methotrexate

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2014
This study will evaluate immune response following administration of zoster vaccine in subjects with rheumatoid arthritis who are receiving background methotrexate and initiate 5 mg twice daily of tofacitinib or placebo for tofacitinib 2 to 3 weeks following vaccination.
Epistemonikos ID: 56fcfcfc61f2c7084fb481430ec54d41b72fc92d
First added on: Mar 23, 2022